Linear Porokeratosis Associated with Disseminated Superficial Actinic Porokeratosis: A New Example of Type II Segmental Involvement

Pediatric Dermatology

Volumn 20, Issue 6, 2003, Pages 514-518

  Del Carmen Boente, María ^a,b   López Baró, Ana M ^a   Del Valle Frontini, María ^a   Asial, Raúl A ^a  

^a Ctro de Invest Dermatologicas   (Argentina)

^b NONE   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINIC POROKERATOSIS; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CASE REPORT; DISEASE ASSOCIATION; DISSEMINATED SUPERFICIAL ACTINIC POROKERATOSIS; FAMILY HISTORY; FEMALE; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; LINEAR POROKERATOSIS; MALIGNANT TRANSFORMATION; ONSET AGE; POROKERATOSIS; POROKERATOSIS MIBELLI; PRESCHOOL CHILD; PRIORITY JOURNAL;

CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOSS OF HETEROZYGOSITY; POROKERATOSIS;

EID: 0347694850     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2003.20613.x     Document Type: Article

References (25)

1. Happle R. Cancer proneness of linear porokeratosis may be explained by allelic loss. Dermatology 1997;195:20-25.
2. Happle R. Somatic recombination may explain linear porokeratosis associated with disseminated superficial actinic porokeratosis [letter]. Am J Med Genet 1991;39:237.
3. Freyschmidt-Paul P, Hoffmann R, Köning A, Happle R. Linear porokeratosis superimposed on disseminated superficial actinic porokeratosis: report of two cases exemplifying the concept of type 2 segmental manifestation of autosomal dominant disorders. J Am Acad Dermatol 1999;41:644-647.
4. Lucker GPH, Steijlen PM. The coexistence of linear and giant porokeratosis associated with Bowen's disease. Dermatology 1994;189:78-80.
5. Schamroth JM, Zlotogorski A, Gilead L. Porokeratosis of Mibelli. Overview of the literature. Acta Derm Venereol (Stockh) 1997;77:207-213.
6. Rahbari H, Cordero AA, Mehregan AA. Linear porokeratosis: a distinctive clinical variant of porokeratosis of Mibelli. Arch Dermatol 1974;109:526-528.
7. Commens CA, Shumack SP. Linear porokeratosis in two families with disseminated superficial actinic porokeratosis. Pediatr Dermatol 1987;4:209-214.
8. Dover JS, Miller JA, Levene GM. Linear porokeratosis of Mibelli and DSAP. Clin Exp Dermatol 1986;11:79-83.
9. Moreland ME, Wyre HW. Porokeratosis. Two morphologic forms within a family. Arch Dermatol 1981;117:245-246.
10. Welton WA. Linear porokeratosis in a family with DSAP. Arch Dermatol 1972;106:263.
11. Fisher C, LeBoit P, Frieden I. Linear porokeratosis presenting as erosions in the newborn period. Pediatr Dermatol 1995;12:318-322.
12. Taniguchi Y, Yuasa T, Shimizu M. Linear porokeratosis. J Dermatol 1993;20:489-492.
13. Goldman GD, Milstone LM. Generalized linear porokeratosis treated with etretinate. Arch Dermatol 1995;131:496-497.
14. Bhushan M, Crawen NM, Beck MH, Chalaiers RJG. Linear porokeratosis of Mibelli: successful treatment with cryotherapy. Br J Dermatol 1999;141:389.
15. Hall J. Somatic mosaicism: observations related to clinical genetics. Am J Hum Genet 1988;43:355-363.
16. Happle R. Segmental forms of autosomal dominant skin disorders: different types of severity reflect different states of zygosity. Am J Med Genet 1996;66:241-242.
17. Happle R. A rule concerning the segmental manifestation of autosomal dominant skin disorders: review of clinical examples providing evidence for dichotomous types of severity. Arch Dermatol 1997;133:1505-1509.
18. Happle R. Mosaicism in human skin: understanding the patterns and mechanisms. Arch Dermatol 1993;129:1460-1470.
19. Happle R. Loss of heterozygosity in human skin. J Am Acad Dermatol 1999;41:143-161.
20. Reed RJ, Leone P. Porokeratosis. A mutant clonal keratosis of the epidermis. Arch Dermatol 1970;101:340-347.
21. Taylor AMR, Harnden DG, Fairburn EA. Chromosomal instability associated with susceptibility to malignant disease in patients with porokeratosis of Mibelli. J Natl Cancer Inst 1973;51:371-378.
22. Scappaticci S, Lambiase S, Orecchia G, Frascaro M. Clonal chromosome abnormalities with preferential involvement of chromosome 3 in patients with porokeratosis of Mibelli. Cancer Genet Cytogenet 1989;43:89-94.
23. Sasaki S, Urano Y, Nakagawa K, Nagae H, Nakanishi H, Arase S. Linear porokeratosis with multiple squamous cell carcinomas: study of p53 expression in porokeratosis and squamous cell carcinoma. Br J Dermatol 1996;134:1151-1152.
24. Bencini PL, Tarantino A, Grimalt R, Ponticelli C, Caputo R. Porokeratosis and immunosuppression. Br J Dermatol 1995;132:74-78.
25. Sasson M & Krain AD. Porokeratosis and cutaneous malignancy. A review. Dermatol Surg 1996;22:239-242.